Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$11.19 - $17.89 $77,211 - $123,441
6,900 Added 222.58%
10,000 $118,000
Q2 2022

Aug 15, 2022

BUY
$9.03 - $21.55 $27,992 - $66,805
3,100 New
3,100 $41,000
Q1 2022

May 16, 2022

SELL
$15.0 - $22.83 $19,500 - $29,678
-1,300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$20.12 - $35.09 $26,156 - $45,617
1,300 New
1,300 $26,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $8.41M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.